DrugPatentWatch Database Preview
Drugs in MeSH Category Nucleic Acid Synthesis Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-003 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-004 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Roxane | HYDROXYUREA | hydroxyurea | CAPSULE;ORAL | 074476-001 | Aug 18, 1995 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-002 | Oct 11, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Addmedica Sas | SIKLOS | hydroxyurea | TABLET;ORAL | 208843-001 | Dec 21, 2017 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-007 | Mar 24, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
